Resistance training for GLP-1 Users | FitOn Health

FitOn HealthApril 275 min read

Resistance Training for GLP-1 Users: What Every Employer Needs to Know

If your employees are on GLP-1 medications, resistance training for GLP-1 users isn't a bonus — it's what the clinical research says should be part of the plan from day one. But most employer benefits strategies don't reflect that. The prescription gets covered. The strength programming doesn't. And the gap between those two things is where results start to slip.

This post breaks down what resistance training actually does for employees on GLP-1s, why it belongs in your benefits strategy alongside the medication, and what it costs when it's not there.

Why resistance training matters for people taking Ozempic

GLP-1 medications like Ozempic, Wegovy, and Mounjaro reduce appetite and drive weight loss through caloric restriction. That's the mechanism, and it works. But when the body is losing weight in a significant caloric deficit, it doesn't only burn fat. Without a consistent signal to preserve lean tissue, muscle breaks down too.

Resistance training is that signal. It tells the body to hold onto muscle while fat comes off — and without it, employees on GLP-1 therapy are losing more than just weight. They're losing the metabolic foundation that makes those results sustainable long-term.

Leading health organizations, including the American College of Sports Medicine, recommends resistance training as a standard for healthy adults. When it comes to GLP-1s, resistance training belongs in your benefits strategy.

What resistance training does for GLP-1 users

The clinical case for pairing strength work with GLP-1 therapy is well established. Here's what the evidence consistently shows when employees engage in regular resistance training during treatment:

Lean mass is preserved. Resistance training signals the body to maintain muscle tissue during weight loss — protecting the metabolic foundation that makes results sustainable long-term.
Resting metabolism stays higher. Muscle is metabolically active tissue. Preserving it keeps resting energy expenditure up, which matters enormously when medication is eventually reduced or stopped.
Fat loss improves. Employees who pair GLP-1 medications with structured movement programming tend to lose more from fat stores, not just overall weight.
Cardiovascular and metabolic markers strengthen. Resistance training improves insulin sensitivity, blood pressure, and lipid profiles — the same markers GLP-1s are improving. When both are working, the gains compound.
Adherence goes up. Many employees engaged in a structured wellness program are more likely to stay on medication long enough to build lasting habits — and less likely to discontinue before durable results are established.
Regain risk drops. At the 12-month mark — when most patients face the question of continuing, tapering, or stopping — employees with established strength habits are in a fundamentally better position to maintain their outcomes.

The benefits strategy gap: GLP-1 coverage alone isn't enough

Most employers are treating GLP-1 coverage as a pharmacy decision — which makes sense, because that's where the cost sits. But the lifestyle side of the equation is where results either hold or reverse.

A benefit that funds the medication without supporting the movement is structurally set up for a predictable outcome: significant weight loss during the treatment window, followed by significant regain when medication changes. One trial found that participants regained approximately two-thirds of their weight loss within 12 months of stopping semaglutide. That's a metabolic reality — and resistance training is one of the primary tools that changes that trajectory.

77% of large employers say managing GLP-1 costs is extremely or very important. The path forward is building infrastructure that makes the investment pay off.

What effective resistance training support looks like for Ozempic and Wegovy users

Effective strength programming for employees on GLP-1s doesn't require intensity — it requires consistency and accessibility. That's an important distinction because the barrier for most employees isn't motivation. It's not knowing where to start, especially when energy levels may fluctuate during early treatment.

What actually works for this population:

Progressive, low-barrier entry points. Bodyweight movements, resistance bands, and light weights are clinically sufficient to preserve lean mass — and far more sustainable for employees who are new to strength training or managing side effects in the early weeks on medication.
Consistency over intensity. Two to four sessions per week of 15-30 minutes is typically enough to generate a meaningful muscle-preserving stimulus. Building a repeatable habit matters more than maximizing load.
Both digital and in-person access. Employees vary in schedule, geography, and preference. A benefit that offers only one modality reaches only part of the workforce. Hybrid access drives broader, more sustained engagement.
Programming timed to the treatment arc. The six-month plateau is when motivation dips and adherence challenges surface. Strength-focused programming is especially high-value here — when appetite suppression starts to moderate and behavioral habits need to do more of the work.
Nutrition support alongside movement. Resistance training only preserves muscle when protein intake supports it. Employees on GLP-1s are often eating significantly less, which makes protein prioritization a priority.

How to assess whether your current benefit covers this

Most wellness benefits weren't designed with Ozempic or Wegovy users in mind. A few questions worth asking as you evaluate your current coverage:

Are employees on GLP-1s proactively connected to strength and resistance programming — or expected to seek it out on their own?
Does your wellness benefit include access to structured strength training, both digitally and in person?
Is there a nutrition component that specifically addresses protein and micronutrient needs during GLP-1 therapy?
Do you have a defined support plan for employees at the six-month plateau and the 12-month decision point?
Are you measuring outcomes beyond weight, including physical fitness engagement, adherence trends, and downstream claims data?

If those gaps are present, the GLP-1s & The Lifestyle Gap guide from FitOn Health walks through the clinical and financial picture in detail, including a strategy checklist built specifically for HR and benefits teams.

How FitOn Health supports resistance training for GLP-1 users

FitOn Health is the all-in-one health and wellness benefit built to fill exactly this gap. Our programs are designed to support employees on GLP-1s, with structured resistance and strength programming, protein-forward nutrition courses, and whole-person well-being support that addresses sleep and stress alongside movement.

That means the largest variety of in-person fitness locations plus premium digital workouts — strength training, HIIT, yoga, and low-impact options — accessible wherever your employees are. Paired with condition-based nutrition education and behavioral support tailored to the specific needs of GLP-1 users at every phase of treatment.

The result: a GLP-1 benefit strategy that protects what you're already investing — and gives your people the tools to make results last beyond the prescription.

Explore the Weight Loss Companion Program →